Business Summary
|
Hybridoma technology is a technology of forming hybrid cell lines (hybridomas) by fusing a specific antibody-producing B cell with a myeloma (B cell cancer) cell that is selected for its ability to grow in tissue culture and for an absence of antibody chain synthesis. The antibodies produced by the hybridoma are all of a single specificity and are therefore monoclonal antibodies.
|
|
|
|
|
|
Related Businesses...
|
The Vintage
Washington, District of Columbia, USA
Biotechnology, Real Estate
|
|
singapore attraction pass
Massapequa, New York, USA
Accounting, Biotechnology
|
|
Efficient Sonics Ltd
Cheshire, United Kingdom
Biotechnology
|
|
faure jean-luc
le pontet, France
Biotechnology, Business Opportunity
|
|
epitope mapping
Shirley, New York, USA
Biotechnology
|
|
|